Stocktoria

Fulgent Genetics, Inc. FLGT

Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2016-09-28
Chart by TradingView
3/9
Piotroski F — financial health
14.32
Altman Z″ — distress risk · safe
Dividend payout · no dividend

Financials & ratios (annual, from 10-K)

MetricFY2025FY2024FY2023FY2022FY2021
Financials
Revenue$322.7M$283.5M$289.2M$619.0M$992.6M
Gross profit$130.9M$107.2M$104.5M$366.9M$777.1M
Operating income-$91.1M-$73.9M-$195.5M$178.5M$676.0M
Net income-$60.5M-$42.7M-$167.8M$143.4M$507.4M
Operating cash flow-$101.6M$21.1M$27.0M$253.5M$538.6M
Free cash flow-$124.2M-$19.3M$4.8M$234.7M$514.8M
Total assets$1.2B$1.2B$1.2B$1.4B$1.3B
Total liabilities$106.8M$90.8M$102.0M$116.2M$112.8M
Shareholders' equity$1.1B$1.1B$1.1B$1.3B$1.2B
Ratios
Gross margin40.6%37.8%36.1%59.3%78.3%
Operating margin-28.2%-26.1%-67.6%28.8%68.1%
Net margin-18.8%-15.1%-58.0%23.2%51.1%
FCF margin-38.5%-6.8%1.7%37.9%51.9%
Return on assets-5.0%-3.5%-13.6%10.3%39.7%
Return on equity-5.5%-3.8%-14.8%11.3%43.5%
Current ratio6.484.856.967.135.81
Revenue growth13.8%-2.0%-53.3%-37.6%135.4%

Notable holders (13F)

InvestorSharesValue
RENAISSANCE TECHNOLOGIES LLC18,000$286,200

Why these scores methodology →

Piotroski F-score: 3/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 14.32 (safe)

  • Working capital / assets 0.384
  • Retained earnings / assets 0.437
  • EBIT / assets -0.075
  • Equity / liabilities 10.362

Sector peers

GOOG · MSFT · META · BABA · DIS · HCA · all Services →

Source: SEC EDGAR filings · CIK 0001674930 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.